Breaking #Cannabis #Stock News
-Isracann Biosciences (CSE: $IPOT.C) Hires Expert Consultancy LinC to Steer
Israeli Cannabis Project
Expert Agronomic and Project
Management Knowledge Vital to Early Success
VANCOUVER,
BC, November 14, 2019 ( Investorideas.com Newswire ) – Isracann Biosciences Inc.
(CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company
focused on becoming a premier low cost, high quality cannabis producer for both
domestic and European export sales, has engaged the services of LinC by Growing
Smart Ltd. to deliver a formal project characterization roadmap for the
successful development of its proposed 230,000 sq. ft. purpose-built production
facility.
The
project characterization, is an in depth and detailed document profiling the
site-specific seasonal climatic conditions, including daily hours of sun,
average daily/nightly high and low temperatures, daily humidity levels, and UV
index levels. With that information, the project characterization determines
necessary greenhouse environmental controls and equipment for dehumidification,
air circulation, shading screens, active heating, cooling and carbon dioxide
enrichment.
LinC
is the cannabis specific arm of Grow Smart Ltd, with offices in Tel Aviv,
Israel and Shanghai, China. The company is an international agricultural
project management company supplying turnkey projects for the cannabis sector
delivering individually tailored solutions to the unique needs of each project.
In
addition to developing the project characterization for Isracann, LinC has been
contracted to provide site-specific cannabis agronomic services. Leading LinC’s
agronomics team is Tal Saadon, who holds a Master of Science in Agronomy with
over 10 years of commercial agriculture experience, primarily in greenhouse
cannabis cultivation from seed, harvest and drying processes through to extensive
experience working with multiple growers and the various arms of the Ministry
of Health. The team also includes second generation farmer Tal Tregerman, who
comes from a core founding family of an important agricultural Moshav (co-op
agri-community) in the prolific Negev region. Tregerman originally established
IMC Ltd., one of the first successful outdoor cannabis greenhouses in Israel
and firmly established his ability to develop farm concepts into successful
active operations.
LinC’s
team collaborates across the industry by working with growers, entrepreneurs,
investors, agricultural research centers, agricultural technology and input
companies alike. These efforts translate into over 20 years direct experience successfully
serving the medical cannabis industry in Israel and abroad. The company’s role
extends well beyond the initial planning phase by providing technical,
business, construction and financial solutions as well as ongoing knowledge
transfer and support throughout the entire lifecycle of Isracann’s production
facility.
Company
CEO Darryl Jones comments, “When we initially undertook this project, we knew
we would need to bring onboard a quality team with the knowledge and experience
to achieve timely results. LinC is that team, and we are very appreciative that
they were amenable to working with us. We know they have a long list of
potential projects available to them and we have worked long and hard to ensure
we are a priority with what is expected in the coming months. Their enthusiasm
for our project has been highly motivational to everyone concerned and we look
forward to implementing their detailed approach to developing what we
collectively believe will be one of the most efficient, highest-quality and
lowest cost licensed export production facilities throughout the entire
region.”
ON
BEHALF OF THE BOARD OF DIRECTORS
“Darryl Jones”
Darryl Jones
Chief
Executive Officer and President
About
Isracann Biosciences Inc. (CSE: IPOT) (XFRA:
A2PT0E) (OTC: ATLED)
Isracann is an Israeli-based cannabis company
focused on becoming a premier cannabis producer offering low-cost production targeting
undersupplied, major European marketplaces. Based in Israel's agricultural
sector, Isracann will leverage its development within the most experienced
country in the world with respect to cannabis research. The Company has secured agreements within Israel for
medicinal marijuana cultivation. For more information visit: www.isracann.com.
All statements,
other than statements of historical fact, included herein are forward-looking
statements that involve various risks and uncertainties. There can be no assurance
that such statements will prove to be accurate and actual results and future
events could differ materially from those anticipated in such statements.
Important factors that could cause actual results to differ, materially from
the Company’s expectations are disclosed in the Company’s documents filed from
time to time with the Canadian Securities Exchange, the British Columbia
Securities Commission, the Ontario Securities Commission, and the Alberta
Securities Commission.
Contact
Investor
Relations
Toll
Free: +1 855.205.0226
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. Disclosure : this news release featuring CSE: IPOT is a paid for
news release on Investorideas.com ($750) More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
No comments:
Post a Comment